| 000 | 02637 a2200757 4500 | ||
|---|---|---|---|
| 005 | 20250517231218.0 | ||
| 264 | 0 | _c20181012 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a1349-7006 | ||
| 024 | 7 |
_a10.1111/cas.13752 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKato, Yuka | |
| 245 | 0 | 0 |
_aCombined effect of cabozantinib and gefitinib in crizotinib-resistant lung tumors harboring ROS1 fusions. _h[electronic resource] |
| 260 |
_bCancer science _cOct 2018 |
||
| 300 |
_a3149-3158 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnilides _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, Differentiation, B-Lymphocyte _xgenetics |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCrizotinib |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 |
_aErbB Receptors _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGefitinib |
| 650 | 0 | 4 |
_aHeparin-binding EGF-like Growth Factor _xmetabolism |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class II _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred NOD |
| 650 | 0 | 4 |
_aOncogene Proteins, Fusion _xgenetics |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 |
_aQuinazolines _xpharmacology |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xmetabolism |
| 650 | 0 | 4 |
_aSodium-Phosphate Cotransporter Proteins, Type IIb _xgenetics |
| 650 | 0 | 4 | _aUp-Regulation |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 650 | 0 | 4 | _aAxl Receptor Tyrosine Kinase |
| 700 | 1 | _aNinomiya, Kiichiro | |
| 700 | 1 | _aOhashi, Kadoaki | |
| 700 | 1 | _aTomida, Shuta | |
| 700 | 1 | _aMakimoto, Go | |
| 700 | 1 | _aWatanabe, Hiromi | |
| 700 | 1 | _aKudo, Kenichiro | |
| 700 | 1 | _aMatsumoto, Shingo | |
| 700 | 1 | _aUmemura, Shigeki | |
| 700 | 1 | _aGoto, Koichi | |
| 700 | 1 | _aIchihara, Eiki | |
| 700 | 1 | _aNinomiya, Takashi | |
| 700 | 1 | _aKubo, Toshio | |
| 700 | 1 | _aSato, Akiko | |
| 700 | 1 | _aHotta, Katsuyuki | |
| 700 | 1 | _aTabata, Masahiro | |
| 700 | 1 | _aToyooka, Shinichi | |
| 700 | 1 | _aMaeda, Yoshinobu | |
| 700 | 1 | _aKiura, Katsuyuki | |
| 773 | 0 |
_tCancer science _gvol. 109 _gno. 10 _gp. 3149-3158 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cas.13752 _zAvailable from publisher's website |
| 999 |
_c28676635 _d28676635 |
||